Target site penetration of fosfomycin in critically ill patients.
Joukhadar C, Klein N, Dittrich P, Zeitlinger M, Geppert A, Skhirtladze K, Frossard M, Heinz G, Müller M.
Joukhadar C, et al.
J Antimicrob Chemother. 2003 May;51(5):1247-52. doi: 10.1093/jac/dkg187. Epub 2003 Mar 28.
J Antimicrob Chemother. 2003.
PMID: 12668580
Clinical Trial.